Bladder Cancer - Results from #160

French AFU Cancer Committee Guidelines - Update 2022-2024: Non-muscle-invasive bladder cancer (NMIBC). November 22, 2022

Impact of Finasteride on Survival in Bladder Cancer: A Retrospective Multi-institutional Database Analysis. November 22, 2022

French AFU Cancer Committee Guidelines - Update 2022-2024: Muscle-Invasive Bladder Cancer (MIBC). November 22, 2022

The Efficacy of Chemoradiotherapy for Organ Preservation in Patients with Localized Bladder Cancer - Expert Commentary November 21, 2022

Analysis of MRE11 and Mortality Among Adults With Muscle-Invasive Bladder Cancer Managed With Trimodality Therapy. November 21, 2022

Case report: Metastatic urothelial cancer with an exceptional response to immunotherapy and comprehensive understanding of the tumor and the tumor microenvironment. November 21, 2022

A Phase II Open-label Randomized Controlled Trial of Adjuvant Chemohyperthermia in Patients with Bladder Cancer - Expert Commentary November 18, 2022

Uretero-enteric Strictures After Robot Assisted Radical Cystectomy: Prevalence and Management Over Two Decades. November 18, 2022

A novel focal adhesion-related risk model predicts prognosis of bladder cancer -- a bioinformatic study based on TCGA and GEO database. November 18, 2022

Standard transurethral resection versus transurethral laser surgery for bladder cancer: A systematic review and meta-analysis comparing clinical outcomes and complications. November 17, 2022

Reduced IQGAP2 Promotes Bladder Cancer through Regulation of MAPK/ERK Pathway and Cytokines. November 17, 2022

Immune Response Mediates the Antitumor Activity of EZH2 Inhibition in Bladder Cancer - Expert Commentary November 16, 2022

The prognostic role of p53 and its correlation with CDK9 in urothelial carcinoma. November 16, 2022

Systematic review on oncologic outcomes on adjuvant endovesical treatment for non-muscle invasive bladder cancer in patients with solid organ transplant. November 16, 2022

Association Between T Cell Exhaustion, Urinary Tumor DNA Levels, and BCG Failure in Bladder Cancer - Expert Commentary November 15, 2022

Impact of Programmed Death-ligand 1 Expression on Oncological Outcomes in Patients with Muscle-invasive Bladder Cancer Treated with Radiation-based Therapy. November 15, 2022

Quantitative multiparametric MRI as a promising tool for the assessment of early response to neoadjuvant chemotherapy in bladder cancer. November 15, 2022

IL-15 Superagonist NAI in BCG-Unresponsive Non–Muscle-Invasive Bladder Cancer November 14, 2022

The effect of urinary diversion on renal function after cystectomy for bladder cancer: comparison between ileal conduit, orthotopic ileal neobladder, and heterotopic ileocecal pouch. November 14, 2022

Preliminary efficacy of [90Y]DOTA-biotin-avidin radiotherapy against non-muscle invasive bladder cancer. November 14, 2022

Page 9 of 454

email news signup